Search
Selected Filter
Displaying 1–10 of 55 podcasts results
-
Eye on the Cure Podcast | Episode 85: Cindy Elden
Eye on the CureCindy Elden talks about her journey with Usher syndrome type 3 (USH3), the decades-long work and persistence of her non-profit, and the clinical trial it launched for an USH3 small molecule therapy.
-
Eye on the Cure Podcast | Episode 84: How to Contact Congress
Eye on the CureIn this episode of Eye on the Cure, Jen Bernstein at Horizon Government Affairs, and Sharon King of Taylor’s Tale, talk to host Ben Shaberman about how to schedule and conduct a visit with your House Member in your local district to advocate for important issues. With federal eye research funding at great risk and a Congressional district work period coming in mid-April, now is an ideal time to schedule a visit with your House Member.
-
Eye on the Cure Podcast | Episode 83: Michel Michaelides
Eye on the CureProfessor Michaelides talks about the extraordinary vision improvements for young blind children receiving gene therapy for LCA4
-
Eye on the Cure Podcast | Episode 82: Aaron Nagiel, MD, PhD
Eye on the CureDr. Nagiel discusses how gene therapy is administered to the retina, the surgery and recovery for patients, and the vision improvements for young patients receiving LUXTURNA, the first FDA-approved gene therapy for the eye or an inherited condition.
-
Eye on the Cure
The Eye on the Cure Podcast from the Foundation Fighting Blindness provides science information, news, and insights from the world of vision and retinal diseases. The podcasts are hosted by Ben Shaberman, vice president, science communications, and often include conversations with guests from the research and vision communities.
-
Eye on the Cure Podcast | Episode 81: Ricky Enger
Eye on the CureRicky Enger, the Director of Practical Help for Hadley, talks with host Ben Shaberman about her personal and professional journeys as someone born completely blind.
-
Eye on the Cure Podcast | Episode 80: Aniz Girach, MD
Eye on the CureAniz Girach talks about the company’s emerging protein-splicing therapy for Stargardt disease which has received clearance from the FDA to move into a clinical trial.
-
Eye on the Cure Podcast | Episode 79: Damon Lembi
Eye on the CureDamon Lembi talks about his journey as a college baseball star, father, and CEO of Learnit.
-
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
Eye on the CureDr. Rowan talks about the impact of the glycemic index, microbiome, and diet on the development of age-related macular degeneration and optimization of overall retinal health.
-
Eye on the Cure Podcast | Episode 77: Dr. Bob Bell
Eye on the CureDr. Bell, the CSO of Ascidian Therapeutics, talks about STELLAR, the company’s Phase ½ clinical trial for its emerging RNA-rewriting therapy for Stargardt disease (ABCA4 mutations).
.png)
.png)
.png)
